摘要
基于撤稿观察数据库,以生物医药领域COVID-19相关的撤稿论文为研究对象,分析撤稿论文中的学术不端现象,并就重大公共卫生事件背景下的学术论文科研诚信问题提出了一些思考与建议:探讨了重大公共卫生事件下科研诚信与学术论文出版速度的辨证关系,通过对学术论文的出版后再评价常态化完善科研诚信监督机制,通过加强学术论文数据管理和共享建立并完善科研诚信应急管理机制,重视生物医药领域的利益冲突问题,充分发挥学术期刊的公信力和传播优势解释学术争鸣,以及进一步夯实我国学术论文科研诚信建设。
Based on observations from a retraction database,this study focuses on retracted papers related to corona virus disease 2019 in the field of biomedicine.It analyzes instances of academic misconduct in retracted papers and provides reflections and suggestions on research integrity issues in academic papers under the background of major public health events.The study explores the dialectical relationship between research integrity and the speed of academic paper publication in the context of major public health events.It suggests improving the supervision mechanism of research integrity through post-publication evaluation of academic papers.The study also emphasizes the establishment and improvement of an emergency management mechanism for research integrity by enhancing data management and sharing of academic papers.Addressing conflicts of interest in the field of biomedicine is crucial,and leveraging the credibility and communication advantages of academic journals is essential to interpret academic debates.Finally,the study advocates for further solidifying the construction of research integrity in Chinese academic papers.
作者
许媛媛
崔云裳
陈钰
张群
XU Yuanyuan;CUI Yun-shang;CHEN Yu;ZHANG Qun(Academic Publishing Office,Chinese Center for Disease Control and Prevention,Beijing 102206,China)
出处
《医学与哲学》
北大核心
2024年第3期17-21,共5页
Medicine and Philosophy
基金
2019年中国科技期刊卓越行动计划项目(卓越计划-C-095)
2023年中国科技期刊编辑学会基金项目(CESSP-2023-13)。
关键词
撤稿
学术论文
新型冠状病毒感染
科研诚信
retraction
academic article
corona virus disease 2019
research integrity
